MCC
RGNX icon

Money Concepts Capital’s Regenxbio RGNX Stock Holding History

Money Concepts Capital’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,245
Closed -$572K – 450
2023
Q1 		$572K Buy
30,245
+315
+1% +$6.97K 0.03% 279
2022
Q4 		$679K Sell
29,930
-133
-0.4% -$3.01K 0.03% 364
2022
Q3 		$795K Buy
30,063
+29,473
+4,995% +$874K 0.05% 249
2022
Q2 		$15K Sell
590
-41
-6% -$1.02K ﹤0.01% 953
2022
Q1 		$21K Buy
+631
New +$17.5K ﹤0.01% 1598

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Money Concepts Capital's RGNX Position: Q2 2023 in Review

Money Concepts Capital sold out of Regenxbio (RGNX) in Q2 2023, closing a stake of 30,245 shares — an estimated $572K sold.

Money Concepts Capital first reported a position in RGNX in Q1 2022 and held it in 5 quarters. The position peaked at $795K in Q3 2022. 166 funds tracked by Wall St. Rank hold RGNX as of Q2 2023.

  • Money Concepts Capital reported no remaining Regenxbio position as of Q2 2023 after selling out during the quarter.
  • Money Concepts Capital sold 30,245 Regenxbio shares in Q2 2023, an estimated $572K.
  • Money Concepts Capital first reported a position in Regenxbio in Q1 2022 and held it in 5 quarters.
  • Money Concepts Capital's Regenxbio position peaked at $795K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q2 2023.

Based on Money Concepts Capital's 13F filing for Q2 2023, filed 1 Aug 2023.